5Gabriel SG, David RH. Inherited and acquired thrombophilias and poor pregnancy outcome:should we be treating with beparin [ J ]. Obstet Gynecol, 2003,15 ( 2 ) : 501 - 506.
6Moor E, Silveira A, vant Hooft F, et al. Coagulation factorⅦ mass and activity in young men with myocardial infarction at a young age: role of plasma lipoproteins and facto r Ⅶ genotype [ J ]. A rterioscler Thromb V asc Boil, 1995,15:655.
7Grandone E, Margaglion M, Colaizzo D, et al. Am [ J ]. Obstet Gyneeol, 1998,179 (5) : 1324 - 1328.
8Emmerich J, Mhene-Gelas M, Aillaud MF, et al. Clinical features in 36 patients homozygour for the BRG 506-GLN factor V mutation [ J ]. Thromb Haemost, 1997,77 ( 4 ) : 620 - 623.
9Tcscsto A, Missiagha E, Gatto E, et al. The TITA project : phenotypic resistance to activated proteinc and FV Feiden mutation in the general popullation [ J ]. Thromb Haemost, 1997,78 (2) :859 - 863.
10Daldback B, Carlsson M, Svensson PJ. Fanfilial thrombophilia due to a previously unecognised mechanism characterized by poor an ticoagulant response to activated protein c : prediction of a cofactor to activated protein C [ J ]. Proc Natl Aead Sci USA, 1993,90(3 ) : 1004 - 1008.
